Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

pany will host a management presentation at 2 p.m. Pacific Time on Thursday, January 24, 2013, to discuss the results.  To access the live webcast, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.  By automating highly complex and time-consuming manual procedures, the Company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases.  Through its strong molecular biology capabilities, the Company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

Use of Non-GAAP MeasuresThe Company has supplemented its reported GAAP financial information with non-GAAP measures that do not include litigation settlement expenses, employee stock-based compensation expense, a non-cash charge associated with the termination of a patent license, impairment of intangible assets and licenses and amortization of purchased intangible assets.  The presentation of this additional information is not meant to be considered in isolation or as a substitute for results prepared in accordance with U.S. GAAP.
The Company's management uses the non-GAAP information internally to evaluate its ongoing bu
'/>"/>

SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Cepheid to Webcast Upcoming Financial Presentations
2. Cepheid Announces Executive Vice President Emerging Markets
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., ... therapeutics, including those with rare and orphan inflammatory disease ... the U.S. Food and Drug Administration (FDA) to begin ... candidate, acebilustat (CTX-4430), in adult CF patients in the ... Europe will be filed soon ...
(Date:7/6/2015)... FRANCISCO, Calif. , July 6, 2015 ... pharmaceutical company, and Oculeve, a development-stage medical device company ... today announced that they have entered into an agreement ... transaction.  Under the terms of the agreement, Allergan will ... commercialization milestone payments related to Oculeve,s lead development program ...
(Date:7/6/2015)... , July 6, 2015 China Information Technology, Inc. ... provider of integrated cloud-based platform, exchange, and big data ... that the Company launched its mobile app for Healthcare ... healthcare services on mobile devices. The Company jointly hosted ... Family Planning Bureau and Shenzhen News Net.   ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... Naviscan, Inc., the worldwide leader in 3D Molecular ... PhD has joined the Naviscan Board of Directors. ... related to reimbursement in the medical device industry.  He ... Reimbursement at Acclarent, Inc.  After acquisition by Ethicon, Inc., ...
... Calif., July 14, 2011 Molecular Devices, LLC, ... & development, life science research, and bioassay/test development, ... Accreditation (A2LA) has accredited the Laboratory Quality System ... re-calibration processes. (Logo: http://photos.prnewswire.com/prnh/20100406/SF82092LOGO ...
Cached Medicine Technology:Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng 2Molecular Devices Continues to Lead the Way in Quality Control and Validation Compliance With a New ISO/IEC 17025 Accreditation 2
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck pain is ... located in the neck. Another 19% suffer from head, migraine, or facial pain, in ... that 45% of American workers must deal with neck pain. Strategies for ...
(Date:7/3/2015)... ... , ... The Harvest Hope Food Bank will hopefully be getting a large donation ... in the area of Greenville SC are making it their mission to collect as many ... are asking for donations from the public as well. As part of the canned food ...
(Date:7/3/2015)... ... July 03, 2015 , ... Rheumatology ... 2015 Annual Conference , the premiere continuing education and networking event for ... SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts in immunology, ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national president recruitment for Regional ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Smoothies are ... is a good blender and easily accessible, quality ingredients. Aurora Natural is proud to ... for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
... Western society are suffering from auto-immune diseases. Discovering the ... step in the search for targeted medicines. VIB researchers ... joined forces and have elucidated the function of MALT1, ... are the first to show that MALT1 is able ...
... rumi regulates Notch signaling by adding a glucose molecule ... outside a cell, said researchers from Baylor College of ... York in a report that appears today in the ... protein determines cell fate determination and differentiation. , ...
... Comment, ROLLING MEADOWS, Ill., Jan. 26 ... member specialty,organization of leaders in the field of ... the petition filed by Public Citizen with the,U.S. ... The ASDS supports the current labeling of all ...
... 25 The,American Society of Plastic Surgeons (ASPS) ... products and adverse events following,a recent petition from ... Citizen requested the U.S. Food and Drug,Administration (FDA) ... More than one million people have been ...
... Costs have climbed 32% since 2002, study finds ... and economic costs in the United States hit $174 ... a new study shows. , The research, commissioned by ... for people with diabetes were about $116 billion, and ...
... attempt to end own life, study finds , , FRIDAY, Jan. 25 ... likely to attempt suicide and more than twice as likely to ... study says. , Violent suicide includes hanging, the use of a ... of a vehicle, or drowning. , The increased risk of suicide ...
Cached Medicine News:Health News:A major step toward a more targeted treatment for auto-immune diseases? 2Health News:Notch-ing glucose into place 2Health News:American Society for Dermatologic Surgery Supports Current Labeling of Allergan's Botox(R) Products 2Health News:ASPS Addresses Concerns Regarding BOTOX Treatments 2Health News:Diabetes' Health Toll Hits $174 Billion Annually 2Health News:Short Birth Length Boosts Men's Suicide Risk 2
9 mm wide tip. Designated most popular model or size....
4 mm wide tip. Designated most popular model or size....
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size....
Designated most popular model or size. 4 mm wide tip....
Medicine Products: